Apart from AML, C/EBPβ shows pro-oncogenic activities in other tumors, such as tumors of the colon, prostate, ovaries, kidneys and the stomach, where C/EBPβ expression often correlates with increased malignancy and invasive activity of the tumor cells [43–45]. Here, CEBPB is linked to neoplasm.